Ozempic and Your Heart: What the 2025 Data Really Shows
A board-certified cardiologist breaks down the 2025 data on GLP-1 drugs like Ozempic and Wegovy, walking through the SELECT trial, the LEADER trial, and a massive meta-analysis showing real drops in heart attacks, strokes, and death.
He also tackles the muscle loss fear directly and shares his actual protocol for losing fat while keeping strength.
Read the full post: https://dralo.net/blog/ozempic-heart
Questions this episode answers:
Does Ozempic actually protect your heart?
What did the SELECT trial find about semaglutide and heart disease?
Does Ozempic cause muscle loss?
Are GLP-1 drugs safe for people without diabetes?
How do I lose fat without losing muscle on Ozempic?
What is the LEADER trial for liraglutide?
Keywords: ozempic heart health, wegovy cardiovascular, glp1 receptor agonists, select trial semaglutide, leader trial liraglutide, ozempic muscle loss, ozempic face, semaglutide heart attack risk, glp1 protein protocol, cardiologist ozempic, weight loss drugs heart disease, ozempic resistance training
This episode is for education only and is not medical advice. Talk to your own clinician about your own situation.
#heart #cardiology #drAlo #ozempic #glp1 #heartdisease #wegovy
